Mitral valve prolapse (MVP) is a common congenital abnormality of the heart that can cause severe complications such as arrhythmias, heart failure, and sudden cardiac death. To date, the causes of MVP ...

Genetic mutations in heart valve cells of the developing fetus lead to mitral valve prolapse, report a global collaborative of researchers. These mutations or genetic variations cause defects in ...

NOTE: A link to videos of the developing heart is at end of the release. The human heart confounds logic by starting to beat before it is fully formed —a developmental oddity shared by all vertebrate ...

WASHINGTON (Reuters) – A non-surgically implanted heart valve meant to delay open heart surgery in children with congenital heart defects worked well for all but a few patients during a year of follow ...

Newborn-asian-baby-heart_G_864026954 The world's smallest mechanical heart valve was approved by the FDA for newborns and young infants with heart defects. (HealthDay News) — The US Food and Drug ...

European medtech Xeltis announced that its restorative heart valve, the world’s first, has been implanted in three children participating in a clinical trial. The bioabsorbable pulmonary heart valve ...

Bicuspid aortic valve (BAV), the most common heart valve birth defect, is associated with genetic variation in human primary cilia during heart valve development, report researchers. Crucial to cilia ...

KOCHI: Once upon a time, the only option to treat heart diseases was open heart surgery. As technology developed, the possibilities for treating heart conditions through minimally invasive procedures ...

A global research collaborative including Medical University of South Carolina investigators report in today's Science Translational Medicine that defects in the primary cilia of the developing fetus ...

WASHINGTON (Reuters) - A non-surgically implanted heart valve meant to delay open heart surgery in children with congenital heart defects worked well for all but a few patients during a year of follow ...

WASHINGTON, March 30 (Reuters) - A non-surgically implanted heart valve meant to delay open heart surgery in children with congenital heart defects worked well for all but a few patients during a year ...